The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2015
The data on antimicrobial resistance in zoonotic and indicator bacteria in 2015, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed. ‘Microbiological’ resistance was assessed using epidemiological cut-off (ECOFF) values; for some countries, qualitative data on human isolates were interpreted in a way which corresponds closely to the ECOFF-deﬁned ‘microbiological’ resistance.
In Salmonella from humans, high proportions of isolates were resistant to ampicillin, sulfonamides and tetracyclines, whereas resistance to third-generation cephalosporins was low. In Salmonella and Escherichia coli isolates from fattening pigs and calves under one year of age, resistance to ampicillin, tetracyclines and sulfonamides was frequently detected, whereas resistance to third-generation cephalosporins was uncommon. For the ﬁrst time, presumptive extended-spectrum beta-lactamase (ESBL)-/AmpC-/carbapenemase-production in Salmonella and Escherichia coli was monitored in humans (Salmonella), meat (pork and beef), fattening pigs and calves. Varying occurrence/ prevalence rates of ESBL-/AmpC-producers were observed between countries, and carbapenemase producing Escherichia coli were detected in single samples of pig meat and from fattening pigs from two MSs.
Resistance to colistin was observed at low levels in Salmonella and Escherichia coli from fattening pigs and calves under one year of age and meat thereof. In Campylobacter from humans, high to extremely high proportions of isolates were resistant to ciproﬂoxacin and tetracyclines, particularly in C. coli. In a few countries, a third to half of C. coli in humans were resistant also to erythromycin, leaving few options for treatment of severe Campylobacter infections. High resistance to ciproﬂoxacin and tetracyclines was observed in C. coli isolates from fattening pigs, whereas much lower levels were recorded for erythromycin. Co-resistance to critically important antimicrobials in both human and animal isolates was generally uncommon.
Salmonellosis - Annual Epidemiological Report for 2018
9 Jan 2023 - In 2018, 92 881 laboratory-confirmed cases of salmonellosis were reported, out of which 121 were fatal.
Salmonellosis - Annual Epidemiological Report for 2021
20 Dec 2022 - In 2021, 30 EU/EEA countries reported data on salmonellosis. Twenty-six countries reported data using either the 2008, 2012 or 2018 EU case definitions for salmonellosis. Compared with the 2008 and 2012 EU case definitions, the 2018 EU case definition allows nucleic acid determination for laboratory confirmation, and includes a requirement for antimicrobial susceptibility testing and reporting of results. Four countries used another case definition, which was not specified.
The European Union One Health 2021 Zoonoses Report
13 Dec 2022 - This report of the European Food Safety Authority and the European Centre for Disease Prevention and Control presents the results of zoonoses monitoring and surveillance activities carried out in 2021 in 27 MSs, the United Kingdom (Northern Ireland) and nine non-MSs.